ArticleCancer medicine2025

Mono-TKI and TKI Plus ICI in Unresectable Hepatocellular Carcinoma Progression on First-Line Treatment of Lenvatinib: A Real-World Study.

Xue Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.